Reaffirming revenue guidance, especially in a range that is considered robust for the company's scale, is typically viewed positively by the market. It suggests that Maravai LifeSciences is confident in its operational stability and growth prospects, which can lead to increased investor confidence and potentially a positive impact on the stock price in the short term.